We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

3034:TWSENovatek Microelectronics Corp. Analysis

Data as of 2026-06-12 - not real-time

NT$500.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Novatek Microelectronics is trading at TWD 500, comfortably above its 20‑day (485.6), 50‑day (449.4) and 200‑day (410.4) SMAs, confirming a bullish price trend. However, the MACD histogram is negative and the MACD signal is flagged as bearish, while the RSI sits at 60.5, suggesting momentum may be softening near the resistance zone of TWD 512. The stock’s trailing P/E of 18.6 is well below the semiconductor industry average of 36.5, indicating relative cheapness on a earnings basis, yet the DCF‑derived fair value of TWD 259.9 is less than half the market price, yielding a downside estimate of –9.9% and an “overvalued” label. Dividend yield looks attractive at 5.74%, but the payout ratio exceeds 100% (104%), raising concerns about sustainability. Fundamentals show a 14.7% YoY revenue decline, though Q1 2026 gross margin improved to 39% and Q2 guidance projects 19‑23% QoQ revenue growth, which could provide a catalyst if met. Overall, the stock sits in a high‑volatility environment (44% 30‑day) with modest beta (0.48) and mixed technical signals, making short‑term positioning delicate while medium‑term upside hinges on the upcoming earnings beat.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near resistance at TWD 512
  • Bearish MACD histogram
  • High dividend payout ratio (>100%)

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Q2 revenue guidance of +19‑23% QoQ
  • Strong cash position (TWD 48.9B) and low debt
  • Relative earnings cheapness vs industry P/E

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Sustainable ROE (~20%) and solid operating margins
  • Overvalued relative to DCF fair value
  • Potential dividend sustainability concerns

Key Metrics & Analysis

Financial Health

Revenue Growth-14.70%
Profit Margin15.36%
P/E Ratio18.6
ROE20.48%
ROA9.80%
Debt/Equity0.79
P/B Ratio4.2
Op. Cash FlowNT$14.9B
Free Cash FlowNT$8.4B
Industry P/E36.5

Technical Analysis

TrendBullish
RSI60.5
SupportNT$456.00
ResistanceNT$512.00
MA 20NT$485.63
MA 50NT$449.43
MA 200NT$410.43
MACDBearish
VolumeStable
Fear & Greed Index86.71

Valuation

Fair ValueNT$259.91
Target PriceNT$450.65
Upside/Downside-9.87%
GradeOvervalued
TypeBlend
Dividend Yield5.74%

Risk Assessment

Beta0.48
Volatility44.25%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.